EFRACEA

This brand name is authorized in Ireland, Netherlands, Poland, United Kingdom

Active ingredients

The drug EFRACEA contains one active pharmaceutical ingredient (API):

1 Doxycycline UNII N12000U13O - DOXYCYCLINE

Doxycycline is primarily bacteriostatic and is believed to exert its antimicrobial effect by the inhibition of protein synthesis. Read about Doxycycline

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EFRACEA Modified-release hard capsule	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01AA02	Doxycycline	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01A Tetracyclines → J01AA Tetracyclines
Discover more medicines within J01AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 156563, 210278
Country: IE	Health Products Regulatory Authority	Identifier(s): 29226
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 91049
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100249682